Monash QoM Initiative: Enhancing Access to Safe Medicines in LMICs
Exciting News! Monash Pharmacy and Pharmaceutical Sciences (MIPS) has launched The Monash Quality of Medicines (QoM) Initiative, aimed at improving access to safe and effective medicines in low-and middle-income countries (LMICs). With the support of The Ripple Foundation, this initiative will address health inequity by tackling poor-quality and falsified medicines. By leveraging Monash’s expertise and … Read more